Last update 08 Mar 2025
Yantai Yinuoyi Biomedical Technology Co., Ltd.

Yantai Yinuoyi Biomedical Technology Co., Ltd.

Subsidiary Company|
2013|
Shandong Sheng, China
|
www.yenepharma.com

Overview

Tags

Nervous System Diseases
Cardiovascular Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases2
Neoplasms1
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
Small molecule drug2
Top 5 TargetCount
ACHE(Acetylcholinesterase)1

Related

2
Drugs associated with Yantai Yinuoyi Biomedical Technology Co., Ltd.
Edaravone/(+)-2-Decanol
Target-
Mechanism
Neuroprotectants
Active Org.
Simcere Pharmaceutical Group Ltd.Simcere Pharmaceutical Group Ltd. [+6]
Originator Org.
Simcere Pharmaceutical Group Ltd.Simcere Pharmaceutical Group Ltd.
Active Indication
Acute Ischemic Stroke [+5]
Inactive Indication
Intracranial Hemorrhages
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
CN
First Approval Date29 Jul 2020
Mecripyrine Hydrochloride
Target
ACHE
Mechanism
AChE inhibitors
Active Org.
Neurodawn Pharmaceutical Co., Ltd.Neurodawn Pharmaceutical Co., Ltd. [+3]
Originator Org.
Simcere Pharmaceutical Group Ltd.Simcere Pharmaceutical Group Ltd.
Active Indication
Alzheimer Disease [+2]
Inactive Indication-
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
5
Clinical Trials associated with Yantai Yinuoyi Biomedical Technology Co., Ltd.
CTR20210233
/ Active, not recruitingPhase 3
Y-2舌下片治疗急性缺血性卒中III期临床试验——多中心、随机、双盲、平行、安慰剂对照III期临床研究
[Translation] Phase III clinical trial of Y-2 sublingual tablets in the treatment of acute ischemic stroke: a multicenter, randomized, double-blind, parallel, placebo-controlled phase III clinical study
CTR20191246
/ Active, not recruitingPhase 1
评价Y-2舌下片单/多次给药在健康成年受试者中的安全性、耐受性和药代动力学临床研究
[Translation] A clinical study to evaluate the safety, tolerability and pharmacokinetics of single/multiple administration of Y-2 sublingual tablets in healthy adult subjects
NCT03495206
/ Unknown statusPhase 1
Sublingual Y-2(Edaravone And Borneol) Tablet For Acute Ischemic And Hemorrhagic Patients-the SALVAGE Trial
100 Clinical Results associated with Yantai Yinuoyi Biomedical Technology Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Yantai Yinuoyi Biomedical Technology Co., Ltd.
Login to view more data
100 Deals associated with Yantai Yinuoyi Biomedical Technology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Yantai Yinuoyi Biomedical Technology Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 17 Mar 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1
1
1
Phase 3
Other
1
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free